SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-22-002518
Filing Date
2022-11-28
Accepted
2022-11-28 16:07:22
Documents
18
Period of Report
2022-11-25
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 26189
2 LETTER OF DAVIDSON lxrp_ex161.htm EX-16.1 3142
8 lxrp_ex161img3.jpg GRAPHIC 5016
9 lxrp_ex161img4.jpg GRAPHIC 8220
10 lxrp_ex161img5.jpg GRAPHIC 8093
  Complete submission text file 0001640334-22-002518.txt   183247

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20221125.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20221125_lab.xml EX-101.LAB 14635
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20221125_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20221125_pre.xml EX-101.PRE 9260
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20221125_def.xml EX-101.DEF 2099
12 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 3599
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 221425389
SIC: 2834 Pharmaceutical Preparations